Company Overview

Entia Biosciences, Inc. is a U.S.-based bioscience and nutritional products company focused on plant-derived minerals, trace elements, and wellness formulations. The company has historically operated in the health and wellness, nutraceutical, and dietary supplement industries, with product development centered on mineral transport technology and plant-based nutrient delivery systems. Public disclosures and archived company materials indicate that the company has marketed nutritional supplements intended to support cellular health, energy metabolism, and immune function.

The company’s primary business activities have included the development, licensing, and commercialization of proprietary formulations derived from plant-sourced minerals and biologically active compounds. Its revenue generation has historically been tied to dietary supplement sales, intellectual property licensing, and strategic distribution relationships. Available public records suggest the company sought to differentiate itself through claims surrounding bioavailability and mineral uptake technologies. However, current operational scale, active commercial status, and financial performance are difficult to independently verify through recent filings. Data inconclusive based on available public sources.

Business Operations

Historically, Entia Biosciences, Inc. operated through nutritional supplement development and commercialization activities tied to proprietary ingredient formulations and wellness products. The company’s operations appear to have included research partnerships, manufacturing coordination, and direct or distributor-based product sales within the United States. Publicly available disclosures indicate that intellectual property and proprietary formulations represented important business assets, although comprehensive current segment reporting is not publicly available through recent audited filings.

The company’s operations appear to have been primarily domestic, with limited publicly verifiable evidence of large-scale international operations. Available historical materials reference proprietary mineral transport technologies and biologically derived compounds as core assets. Information regarding active subsidiaries, major joint ventures, or significant strategic commercial partnerships could not be consistently verified across recent public records and independent financial databases. Data inconclusive based on available public sources.

Strategic Position & Investments

Publicly available information indicates that Entia Biosciences, Inc. historically pursued growth through nutraceutical innovation, intellectual property development, and wellness-oriented product commercialization. The company emphasized formulations involving plant-derived minerals and trace nutrient delivery systems, positioning itself within broader consumer health and alternative wellness markets. Archived corporate communications and market references suggest management sought opportunities in preventative health and nutritional science sectors.

There is limited verifiable evidence of major recent acquisitions, institutional investments, or large-scale strategic transactions. Similarly, independently confirmed information regarding active portfolio companies, material venture investments, or emerging technology initiatives remains sparse. Publicly accessible corporate disclosures do not provide sufficient detail to conclusively assess current strategic initiatives or capital allocation priorities. Data inconclusive based on available public sources.

Geographic Footprint

Entia Biosciences, Inc. has historically been headquartered in the United States, with operational activity and product marketing primarily focused on domestic wellness and nutritional supplement markets. Publicly available records do not indicate a broad multinational operating footprint comparable to larger life sciences or nutraceutical companies.

Some historical references suggest the company explored broader distribution opportunities beyond the United States, but independently verifiable evidence of material operations across Europe, Asia-Pacific, or Latin America could not be consistently confirmed through recent filings or reliable financial databases. Data inconclusive based on available public sources.

Leadership & Governance

Public information regarding the company’s leadership structure is limited and appears inconsistent across available databases and archived disclosures. Historical records identify executive leadership associated with product commercialization and corporate development efforts, though current governance details are not comprehensively available through recent public filings.

Known historical leadership references include:

• Patrick Kim – Former executive leadership association reported in historical company materials
• Michael J. Bartholomew – Historical executive association referenced in archived public disclosures

Recent independently verified information regarding the current Chief Executive Officer, board composition, executive management team, or governance framework could not be conclusively confirmed through current public filings, including available SEC filings and financial information services. Data inconclusive based on available public sources.